<HTML>
<HEAD>
<TITLE>AOD Thesaurus Annotated Hierarchy: chemical substances by function YJ YM26.2</TITLE>
<META
Name="Description"sA Guide to Concepts and Terminology in Substance Abuse and Addiction">
</META>
<META
Name="Keywords"
Content="classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept">
</META>
</HEAD>
<body bgcolor="#FFFFFF">
<CENTER><B><BIG>AOD Thesaurus.&nbsp;&nbsp;Annotated Hierarchy.&nbsp;&nbsp;chemical substances by function.&nbsp;&nbsp;YJ - YM26.2</BIG></B></Center>
<CENTER><A HREF="aodob.htm#Y">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YJ">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqy.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnye.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><BR><BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ"><B><BIG>YJ</BIG></B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>neuroactive substances</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YJ"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> nervous system related factors </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YK6e neurotransmitter receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+XWe nervous system &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XW"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XW"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ2"><B>YJ2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neurotransmitters</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">ST</TD><TD> neuromodulators </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EB24e neurotransmitter metabolism &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EB24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhne.htm#EB24"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YH2.2.6e epinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YH2.2.6.6e norepinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.6.10.2.2.2e GABA &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.10.8.2.2.2e taurine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-10-8-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-10-8-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18e biogenic amines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18.2e acetylcholine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18.2.2.2e histamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO2.2.4.2e glycine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO2.2.6.2.2e N methyl D aspartate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO2.2.6.4e glutamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZS6.4.2.2e adenosine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS6-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS6-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZDe organic compounds &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZD"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZD"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+EW4e neurochemistry &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EW6e neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EW6.6 chemical neurotransmission &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EW6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EW6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YK6e neurotransmitter receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YK6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV4 neuroregulators &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YV14.4e neurotransmitter uptake inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO4e peptides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ2-2">YJ2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>excitatory neurotransmitters&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZO2.2.6.4e glutamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ2-4">YJ2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>monoamine neurotransmitters&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ4"><B>YJ4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neurosteroids</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>A new area of research concerning alcohol's behavioral actions focuses on a group of endogenous steroids known as neurosteroids, so called, because they are synthesized in the brain from cholesterol,
   a steroid precursor, or as metabolites of *+YG12 sex hormones* <A HREF="aodhqy.htm#YG12"><SMALL>qh</SMALL></A> <A HREF="aodhnye.htm#YG12"><SMALL>ah</SMALL></A> or *+YH4.8 mineralocorticoids* <A
   HREF="aodhqy.htm#YH4-8"><SMALL>qh</SMALL></A> <A HREF="aodhnye.htm#YH4-8"><SMALL>ah</SMALL></A>.  Neurosteroids have a fast action on neuronal membranes when compared with the slow, delayed effects
   of traditional steroids.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> neuroactive steroids </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZV24e endogenous steroids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZV24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZV24"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ4-2">YJ4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>neurosteroid GABA agonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Act as agonists at the GABA A receptor complex to produce neuronal inhibition and behaviorally to exert hypnotic and anxiolytic effects.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>YH4.6.4.6.2e pregnenolone sulfate &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH4-6-4-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH4-6-4-6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ4-2-2">YJ4.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>allopregnanolone&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ4-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ4-4">YJ4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>neurosteroid GABA A antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="27%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Act as antagonists at the GABA A receptor to produce increased neuronal excitability.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZV4.4.2.2e dehydroepiandrosterone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZV4-4-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzu.htm#ZV4-4-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ4-4-2">YJ4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>3-alpha-5-alpha-tetrahydrodeoxycorticosterone&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ6"><B>YJ6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neurohormones</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> THDOC </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ8"><B>YJ8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>nerve growth factors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Maintains neuronal survival, stimulates neurite outgrowth and cell growth, and induces enzymes involved in neurotransmitter synthesis.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> neurotrophic factors </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> neurotrophin </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> NGF </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YM16e growth substances &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+GJ2.16.2.4e alcohol-related intrauterine disorder &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GJ2-16-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngj.htm#GJ2-16-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YJ10"><B>YJ10</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neuroprotective factors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> neuroprotective effects </TD></TR>
 </TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK"><B><BIG>YK</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>receptors</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YK"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A molecule or molecular structure on the surface of a cell or within a cell that selectively binds a specific substance with attendant specific physiological effects.  In contrast, *+XV4.2 sensory
   receptors* <A HREF="aodhqx.htm#XV4-2"><SMALL>qh</SMALL></A> <A HREF="aodhnxv.htm#XV4-2"><SMALL>ah</SMALL></A> are body organs, namely encapsulated nerve endings or special cells.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> membrane receptors </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> membrane-bound receptors </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> receptor binding sites </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZO6.6.14.4e effector domain &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-6-14-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-6-14-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZO6e proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>AE4.4 biological AOD tolerance &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AE4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AE4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>CK2.4e structure activity relationship &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CK2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CK2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG10e cell signaling &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG10.4 chemical cell signaling &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG10-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG10-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG14 cell membrane biology &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG14.2e receptor ligand binding &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG14.8e membrane channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EG14.8.4.2 receptor operated channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XA2.12e cell membrane &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XA2-12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnx.htm#XA2-12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XT4.2e lymphocyte &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XT4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxr.htm#XT4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+XV4.2e sensory receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XV4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XV4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YE2e antibodies &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YE4e antigens &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YE8 complement (serum protein) &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YE10.8e lymphokines &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE10-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE10-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZHe carbohydrates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZH"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZH"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18.2.2.2e histamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO6.4.10.6.4.16e fibrinogen &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-4-10-6-4-16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-4-10-6-4-16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO6.6.14e receptor proteins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-6-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-6-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZS8.14e cAMP &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS8-14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK2"><B>YK2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>hormone receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK4"><B>YK4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neuropeptide receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD>+ZO4e peptides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK4-2">YK4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>purigenic receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZS8.18.2e ATP receptor &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS8-18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS8-18-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6"><B>YK6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>neurotransmitter receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+YJ neuroactive substances &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YJ2e neurotransmitters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-2">YK6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>adrenergic receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+XY6.4.4e sympathetic nervous system &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XY6-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxv.htm#XY6-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YH2.2.6.6e norepinephrine &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-2-6-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-2-6-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12e sympatholytics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.2e alpha-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.4e beta-adrenergic receptor blockaders &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV12.6 adrenergic neurohumor depleters &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV12-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV12-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YV14e sympathomimetics &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YV14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YV14"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-2-2">YK6.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>alpha-adrenergic receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-2-4">YK6.2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>beta-adrenergic receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-4">YK6.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>cholinergic receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> cholinergic system </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-4-2">YK6.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>muscarinic receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-4-4">YK6.4.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotinic receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>BD2e nicotine &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BD2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BD2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+EG14.8e membrane channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-4-4-2">YK6.4.4.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>nicotinic acetylcholinic receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="31%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-6">YK6.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>dopaminergic receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> dopamine receptors </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-8">YK6.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>GABA receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EG14.8.6e chloride channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZJ2.6.10.2.2.2e GABA &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-8-2">YK6.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>GABA A receptor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-10">YK6.10</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>glutamate receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>ZO2.2.6.4e glutamate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-6-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-10-2">YK6.10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>NMDA receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> N methyl D aspartate receptors </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EG14.8.8e calcium channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO2.2.6.2.2e N methyl D aspartate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO2-2-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO2-2-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK6-10-4">YK6.10.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>serotonin receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK6-10-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> 5-HT receptors </TD></TR>
 <TR><TD> </TD><TD> </TD><TD> 5-hydroxytryptamine receptors </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK8"><B>YK8</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>opioid receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">BT</TD><TD>+ZO6.6.14.8e G-protein-coupled receptors &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-6-14-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-6-14-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>ZO6.8.26.4e pro-opiomelanocortin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-8-26-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-8-26-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ16e opiates &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ16"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ16"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ20e endogenous opioids &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZQ20.4e enkephalin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ20-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ20-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK8-2">YK8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>delta-opioid receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> DOR </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK8-4">YK8.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>kappa-opioid receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK8-6">YK8.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>mu-opioid receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK8-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK10"><B>YK10</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>benzodiazepine receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">RT</TD><TD><TT>&nbsp;</TT>EG14.8.6e chloride channel &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EG14-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnef.htm#EG14-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZT6.4.2e benzodiazepines &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK12"><B>YK12</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>nicotinaminic receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK14"><B>YK14</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>immunologic receptors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YK14-2">YK14.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>antigen receptors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YK14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL"><B><BIG>YL</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>agonists and antagonists</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YL"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>An agonist is a substance that can bind at the molecular level to a receptor site to produce a pharmacological action.  The bound agonist at the receptor site can be displaced by its antagonist,
   which has the effect of completely or partially nullifying the pharmacological action of the agonist, depending upon the purity of the antagonist.  Heroin, for example, is an agonist; naltrexone is
   a pure antagonist to heroin; cyclazocine is a mixed antagonist to heroin having some slight agonist properties of its own.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL2"><B>YL2</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>ethanol agonists and antagonists</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL2-2">YL2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>ethanol agonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">BT</TD><TD>+YL4e agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BB2e ethanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE16.4e synergistic drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL2-4">YL2.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>ethanol antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZC18.6.2.2e dimethylsulfoxide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC18-6-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC18-6-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZQ4.6.4e naloxone &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZQ4-6-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzp.htm#ZQ4-6-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YL6e antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+BB2e ethanol &nbsp;&nbsp;&nbsp;<A HREF="aodhqb.htm#BB2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnb.htm#BB2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>EE16.6e antagonistic drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YP4.2e anti-alcohol-intoxication agents &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YP4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm#YP4-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL4"><B>YL4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>agonists</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A substance that can bind at the molecular level to a receptor site to produce a pharmacological action.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>YL2.2 ethanol agonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL2-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL6"><B>YL6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>antagonists</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A drug that blocks or counteracts the effect of another drug.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YD8e enzyme inhibitors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YD8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YD8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YG34 hormone antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YG34"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YG34"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YL2.4 ethanol antagonists &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YL2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZM4e verapamil &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZM4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZM4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE16.6e antagonistic drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.8.6e dopamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YL6-2">YL6.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>non-competitive antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YL6-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<BR>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM"><B><BIG>YM</BIG></B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B><BIG>other biological factors</BIG></B>&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YM"><SMALL>d-out</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>EX8.6.4.2e transcription factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EX8-6-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhneu.htm#EX8-6-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+HF26.2 biochemical markers &nbsp;&nbsp;&nbsp;<A HREF="aodhqha.htm#HF26-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnha.htm#HF26-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZJ2.6.10.2.2.4e endothelin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZJ2-6-10-2-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZJ2-6-10-2-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+AK4.2e biological AODC &nbsp;&nbsp;&nbsp;<A HREF="aodhqa.htm#AK4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhna.htm#AK4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>CK10.2e free radicals &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CK10-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CK10-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YX2e toxins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM2"><B>YM2</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>biochemical messengers</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>The mediator of an effect such as a hormone secreted in one part of an organism and having an effect on distant cells, sometimes operating via a second messenger.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZS4.8.2e mRNA &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS4-8-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS4-8-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM2-2">YM2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>second messengers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>SN</TD>
 <TD>A chemical substance inside a cell that carries information further along the signal pathway from the internal portion of a membrane-spanning receptor embedded in the cell membrane.  It may in the
   form of an enzyme's product or ion fluxes.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> secondary messengers </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZF2.12.4.2.8.6e inositol 1,4,5-trisphosphate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF2-12-4-2-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF2-12-4-2-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+ZA2.4.4.6e calcium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZF2.12.4.2e inositol phosphate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF2-12-4-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF2-12-4-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZK6.2e diglycerides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZS8.14e cAMP &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS8-14"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS8-14"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZS8.26e cGMP &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZS8-26"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzr.htm#ZS8-26"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM2-4">YM2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>intracellular messengers&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+ZF2.12.4.2.8e inositol triphosphate &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZF2-12-4-2-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZF2-12-4-2-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZK6.2e diglycerides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK6-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM4"><B>YM4</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>biological electrolytes</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+GR20e disorder of fluid or electrolyte or acid-base balance &nbsp;&nbsp;&nbsp;<A HREF="aodhqg.htm#GR20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhngo.htm#GR20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+CC10e ion &nbsp;&nbsp;&nbsp;<A HREF="aodhqc.htm#CC10"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnc.htm#CC10"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZA2.4.2.4e sodium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-2-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZA2.4.2.6e potassium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-2-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-2-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZA2.4.4.4e magnesium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-4-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-4-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZA2.4.4.6e calcium &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZA2-4-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZA2-4-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZC10.2.4e chlorides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZC10-2-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZC10-2-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM6"><B>YM6</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>antioxidants</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM8"><B>YM8</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>chemotactic factors</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM10"><B>YM10</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>cell adhesion molecules</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
<TR><TD WIDTH="25%"> </TD><TD WIDTH="5%" VALIGN=TOP>SN</TD>
<TD>Membrane proteins that protrude into the extracellular space and bind to similar molecules on adjacent cells
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM10-2">YM10.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>neural cell adhesion molecules&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM10-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM10-2-2">YM10.2.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>N-CAM&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM10-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM10-2-4">YM10.2.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>L1 molecule&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM10-2-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM12"><B>YM12</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>transmembrane conductance regulators</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM12"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM14"><B>YM14</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>slow-reacting substances</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM14"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD><TD WIDTH="5%">NT</TD><TD>+YH2.4.6e angiotensin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZK4.4.8e prostaglandins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK4-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK4-4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZK4.6e thromboxane &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK4-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK4-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZN2.18.2.2.2e histamine &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZN2-18-2-2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzm.htm#ZN2-18-2-2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO4.24.4e kinin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4-24-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4-24-4"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZT6.10.12.4e serotonin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZT6-10-12-4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzt.htm#ZT6-10-12-4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM14-2">YM14.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>prostaglandin antagonists&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM14-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">ST</TD><TD> prostaglandin D2 </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZK4.4.8e prostaglandins &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZK4-4-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzj.htm#ZK4-4-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD><TT>&nbsp;</TT>EE16.6e antagonistic drug interaction &nbsp;&nbsp;&nbsp;<A HREF="aodhqe.htm#EE16-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhned.htm#EE16-6"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16"><B>YM16</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>growth substances</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> growth factors </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YE10.8.6e interleukin &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE10-8-6"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE10-8-6"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YH2.4.42e epidermal growth factor &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YH2-4-42"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YH2-4-42"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>YJ8e nerve growth factors &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YJ8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YJ8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD><TT>&nbsp;</TT>ZO4.20e platelet-derived growth factor &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4-20"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4-20"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+ZO4.24.8e somatomedin &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4-24-8"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4-24-8"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+YBe vitamins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-2">YM16.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>growth-arresting factors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-4">YM16.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>growth-promoting factors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+YBe vitamins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YB"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhny.htm#YB"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YFe hormones &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YF"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YF"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-6">YM16.6</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>transforming growth factors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-6"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-8">YM16.8</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>fibroblast growth factors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-8"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+ZO4e peptides &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-8-2">YM16.8.2</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>basic fibroblast growth factor&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-8-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>Introduced 2000.
  </TD></TR>
 <TR><TD> </TD><TD>ST</TD><TD> bFGF </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM16-10">YM16.10</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>colony-stimulating factors&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM16-10"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM18"><B>YM18</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>mitogens</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM18"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD><TT>&nbsp;</TT>ZH12.2e lipopolysaccharide &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZH12-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnz.htm#ZH12-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM18-2">YM18.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>lectins&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM18-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">NT</TD><TD><TT>&nbsp;</TT>ZO6.2.6.2e concanavalin A &nbsp;&nbsp;&nbsp;<A HREF="aodhqz.htm#ZO6-2-6-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnzo.htm#ZO6-2-6-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD>BT</TD><TD>+YE2.2 agglutinins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YE2-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnye.htm#YE2-2"><SMALL>ah</SMALL></A></TD></TR>
 <TR><TD> </TD><TD> </TD><TD>+YM24e biological products &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM24"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM20"><B>YM20</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>pulmonary surfactants</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM20"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 1995.
  </TD></TR>
 <TR><TD> </TD><TD>RT</TD><TD>+XK4e lung &nbsp;&nbsp;&nbsp;<A HREF="aodhqx.htm#XK4"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnxf.htm#XK4"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM22"><B>YM22</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>pyrogens</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM22"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24"><B>YM24</B></A><SMALL>e</SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>biological products</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="25%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 <TR><TD> </TD><TD>NT</TD><TD>+YM18.2 lectins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM18-2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyj.htm#YM18-2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-2">YM24.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>toxoids&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD><TD WIDTH="5%">RT</TD><TD>+YX2e toxins &nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YX2"><SMALL>qh</SMALL></A>&nbsp;&nbsp;&nbsp;<A HREF="aodhnyw.htm#YX2"><SMALL>ah</SMALL></A></TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-2-2">YM24.2.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>staphylococcal toxoid&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-2-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="29%"> </TD><TD WIDTH="5%">ST</TD><TD> staphylococcal anatoxin </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-4">YM24.4</A><SMALL>e</SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;</TT></SMALL></B>vaccines&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
 <TABLE WIDTH="100%" CELLPADDING=0><TR><TD WIDTH="27%"> </TD>
 <TD WIDTH="5%" VALIGN=TOP>HN</TD>
 <TD>ETOH descriptor 2000.
  </TD></TR>
 </TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-4-2">YM24.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>bacterial vaccine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-4-4">YM24.4.4</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>viral vaccine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-4-4"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM24-4-4-2">YM24.4.4.2</A><SMALL></SMALL></TD><TD><B><TT><SMALL>.&nbsp;&nbsp;.&nbsp;&nbsp;.&nbsp;&nbsp;</TT></SMALL></B>AIDS vaccine&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM24-4-4-2"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
<BR>
<TABLE WIDTH="100%"><TR><TD WIDTH="20%"><A NAME="YM26"><B>YM26</B></A><SMALL></SMALL></TD><TD><B><TT><SMALL></TT></SMALL></B><B>tissue extracts</B>&nbsp;&nbsp;&nbsp;<A HREF="aodhqy.htm#YM26"><SMALL>qh</SMALL></A></TD></TR>
</TABLE>
</TABLE><BR><BR>
<CENTER><A HREF="aodob.htm#Y">b-out</A>&nbsp;&nbsp;To Broad Outline&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodod.htm#YJ">d-out</A>&nbsp;&nbsp;To Detailed Outline&nbsp;&nbsp;&nbsp;&nbsp;
<A HREF="aodhqy.htm">qh</A>&nbsp;&nbsp;To Quick Hierarchy</CENTER>
<CENTER><A HREF="aodhnye.htm">Previous</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodhnyn.htm">Next</A>&nbsp;Annotated Hierarchy section&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="aodwsrch.htm">Search</A></CENTER><P>classification thesaurus glossary dictionary definition subject heading list ontology vocabulary knowledge structure knowledge organization terminology concept </P>
</BODY>
</HTML>
